Completed |
: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Drug: TLR8 Agonist VTX-2337 Gi
|
Completed |
: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Clear Cell
: 2003-05-06
: - Drug: paclitaxel Given IV
|
Active, not recruiting |
: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor
-
- Biological: Bevacizumab Given
|
Completed |
: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
: - Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
-
- Drug: Carboplatin Given IV
|
Recruiting |
: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
: - Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
- Ovarian Clear
: 2014-03-28
: - Drug: Gemcitabine Hydrochloride
|
Completed |
: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
-
- Biological: Urokinase-Derived Peptide A6
|
Suspended |
: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
: - Nausea and Vomiting
- Ovarian Brenner Tumor
- Ovarian Clear Ce
: 2011-01-11
: - Procedure: Adjuvant Therapy An
|
Completed |
: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Clear Cell
: 2009-10-09
: - Drug: belinostat Given IV
|
Completed |
: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Clear Cell
: 2007-04-25
: - Biological: sargramostim Given
|
Completed |
: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
: - Chemotherapeutic Agent Toxicity
- Endometrial Adenocarcinoma
: 2008-12-20
: - Drug: Paclitaxel Given IV or i
|